Abstract
The immune system is essential for the development and homeostasis of the human body. Our current understanding of the immune system on disease pathogenesis has drastically expanded over the last decade with the definition of additional non-canonical roles in various tissues. Recently, tissue-resident immune cells have become an important research topic for understanding their roles in the prevention, pathogenesis, and recovery from the diseases. Heart resident immune cells, particularly macrophage subtypes, and their characteristic morphology, distribution in the cardiac tissue, and transcriptional profile have been recently reported in the experimental animal models, unrevealing novel and unexpected roles in electrophysiological regulation of the heart both at the steady-state and diseased state. Immunological processes have been widely studied in both sterile cardiac disorders, such as myocardial infarction, autoimmune cardiac diseases, or infectious cardiac diseases, such as myocarditis, endocarditis, and acute rheumatic carditis. Following cardiac injury, innate and adaptive immunity have critical roles in pro- and anti-inflammatory processes. Heart resident immune cells not only provide defense against infectious diseases but also contribute to the homeostasis. In recent years, physiological changes and pathological processes were demonstrated to alter the abundance, distribution, polarization, and diversity of immune cells in the heart. Accumulating evidence indicates that cardiac remodeling is controlled by the complex crosstalk between cardiomyocytes and cardiac immune cells through the gap junctions, providing the ion flow to achieve synchronization and modulation of contractility. This review article aims to review the well-documented roles of both resident and recruited immune cell in the heart, as well as their recently uncovered unconventional roles in both cardiac homeostasis and cardiovascular diseases. We have mostly focused on studies on animal models used in preclinical research, underlying the need for further investigations in humans or in vitro human models. It may be foreseen that the further comprehensive investigations of cardiac immunology might harbor new therapeutic options for cardiac disorders that have tremendous medical potential.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- APD:
-
Action potential duration
- ATP:
-
Adenosine triphosphate
- AVN:
-
Atrioventricular node
- CCR:
-
C-C motif chemokine receptors
- CD:
-
Cluster of differentiation
- CXCL:
-
Chemokine (C-X-C motif) ligand
- CXCR:
-
Chemokine (C-X-C motif) receptor
- DAMPs:
-
Damage-associated molecular pattern
- DC:
-
Dendritic cell
- dsRNA:
-
Double strand RNA
- ECM:
-
Extracellular matrix
- GM-CSF:
-
Granulocyte-macrophage colony stimulating factor
- hsCRP:
-
High sensitivity C-reactive protein
- IL:
-
Interleukin
- LDL-C:
-
Low-density lipoprotein cholesterol
- LPS:
-
Lipopolysaccharide
- LQTS:
-
Long QT Syndrome
- LV:
-
Left ventricle
- MCT :
-
Tryptase-positive mast cells
- MCTC:
-
Tryptase- and chymase-positive mast cells
- MHC:
-
Major histocompatibility complex
- MPO:
-
Myeloperoxidase
- NETs:
-
Neutrophil extracellular traps
- NO:
-
Nitric oxide
- ROS:
-
Reactive oxygen species
- TGF:
-
Transforming growth factor
- TNF-α:
-
Tumor necrosis factor-alpha
References
Bajpai G, Schneider C, Wong N, Bredemeyer A, Hulsmans M, Nahrendorf M et al (2018) The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med 24(8):1234–1245. https://doi.org/10.1038/s41591-018-0059-x
Barin JG, Rose NR, Ciháková D (2012) Macrophage diversity in cardiac inflammation: a review. Immunobiology 217(5):468–475. https://doi.org/10.1016/j.imbio.2011.06.009
Baylis RA, Gomez D, Mallat Z, Pasterkamp G, Owens GK (2017) The CANTOS trial: one important step for clinical cardiology but a Giant leap for vascular biology. Arterioscler Thromb Vasc Biol 37(11):e174–e177. https://doi.org/10.1161/ATVBAHA.117.310097
Bhatia A, Sekhon HK, Kaur G (2014) Sex hormones and immune dimorphism. Sci World J 2014:159150. https://doi.org/10.1155/2014/159150
Bonney KM, Engman DM (2015) Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead. Am J Pathol 185(6):1537–1547. https://doi.org/10.1016/j.ajpath.2014.12.023
Cao DJ, Schiattarella GG, Villalobos E et al (2018) Cytosolic DNA sensing promotes macrophage transformation and governs myocardial ischemic injury. Circulation 137(24):2613–2634. https://doi.org/10.1161/CIRCULATIONAHA.117.031046
Chistiakov DA, Melnichenko AA, Myasoedova VA, Grechko AV, Orekhov AN (2017) Mechanisms of foam cell formation in atherosclerosis. J Mol Med (Berl) 95(11):1153–1165. https://doi.org/10.1007/s00109-017-1575-8
Cozlea DL, Farcas DM, Nagy A, Keresztesi AA, Tifrea R, Cozlea L, Carașca E (2013) The impact of C reactive protein on global cardiovascular risk on patients with coronary artery disease. Curr Health Sci J 39(4):225–231
Dababneh E, Siddique MS (2020) Pericarditis. [Updated 2019 Apr 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431080/
Davis MJ, Tsang TM, Qiu Y, Dayrit JK, Freij JB, Huffnagle GB, Olszewski MA (2013) Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection. MBio 4(3):e00264–e00213. https://doi.org/10.1128/mBio.00264-13
DeBerge M, Shah SJ, Wilsbacher L, Thorp E (2019) Macrophages in heart failure with reduced versus preserved ejection fraction trends in molecular medicine. Trends Mol Med 25(4):328–340. https://doi.org/10.1016/j.molmed.2019.01.002
Devaraj S, Jialal I (2011) C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype. Arterioscler Thromb Vasc Biol 31(6):1397–1402. https://doi.org/10.1161/ATVBAHA.111.225508
Dick SA, Epelman S (2016) Chronic heart failure and inflammation: what do we really know? Circ Res 119(1):159–176. https://doi.org/10.1161/CIRCRESAHA.116.308030
Dick SA, Macklin JA, Nejat S, Momen A, Clemente-Casares X, Althagafi MG, Chen J, Kantores C et al (2019) Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat Immunol 20(1):29–39. https://doi.org/10.1038/s41590-018-0272-2
Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L et al (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464(7293):1357–1361. https://doi.org/10.1038/nature08938
Epelman S, Liu PP, Mann DL (2015) Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol 15(2):117–129. https://doi.org/10.1038/nri3800
Fairweather D, Frisancho-Kiss S, Gatewood S, Njoku D, Steele R, Barrett M, Rose NR (2004) Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection. Autoimmunity 37:131–145. https://doi.org/10.1080/0891693042000196200
Fantin A, Vieira JM, Gestri G et al (2010) Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF- mediated endothelial tip cell induction. Blood 116:829–840. https://doi.org/10.1182/blood-2009-12-257832
Fioranelli M, Bottaccioli AG, Bottaccioli F, Bianchi M, Rovesti M, Roccia MG (2018) Stress and inflammation in coronary artery disease: a review Psychoneuroendocrineimmunology-based. Front Immunol 9:2031. https://doi.org/10.3389/fimmu.2018.02031
Fontes MS, van Veen TA, de Bakker JM, van Rijen HV (2012) Functional consequences of abnormal Cx43 expression in the heart. Biochim Biophys Acta 1818(8):2020–2029. https://doi.org/10.1016/j.bbamem.2011.07.039
Forte WC, Mario AC, da Costa A, Henriques LS, Gonzales CL, Franken RA (2001) Immunologic evaluation in infective endocarditis. Arq Bras Cardiol 76(1):43–52. https://doi.org/10.1590/s0066-782x2001000100005
Gaaloul I, Riabi S, Harrath R, Hunter T, Hamda KB, Ghzala AB, Huber S, Aouni M (2014) Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients. Mol Med Rep 10(6):2811–2818. https://doi.org/10.3892/mmr.2014.2578
George SA, Calhoun PJ, Gourdie RG, Smyth JW, Poelzing S (2017) TNFα modulates cardiac conduction by altering electrical coupling between myocytes. Front Physiol 8:334. https://doi.org/10.3389/fphys.2017.00334
Gilardin L, Bayry J, Kaveri SV (2015) Intravenous immunoglobulin as clinical immune-modulating therapy. Can Med Assoc J 187(4):257–264. https://doi.org/10.1503/cmaj.130375
Gomez I, Duval V, Silvestre JS (2018) Cardiomyocytes and macrophages discourse on the method to govern cardiac repair. Front Cardiovasc Med 5:134. https://doi.org/10.3389/fcvm.2018.00134
Guilherme L, Kalil J (2010) Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol 30:17–23. https://doi.org/10.1007/s10875-009-9332-6
Guilherme L, Kalil J (2015) Rheumatic fever: how streptococcal throat infection triggers an autoimmune disease. In: Infection and autoimmunity, 2nd edn, pp 479–493. https://doi.org/10.1016/B978-0-444-63269-2.00029-5
Guilherme L, Kalil J, Cunningham M (2006) Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 39(1):31–39
Guilherme L, Köhler KF, Kalil J (2012) Rheumatic heart disease: genes, inflammation and autoimmunity. Rheumatol Curr Res S4:001. https://doi.org/10.4172/2161-1149.S4-001
Hajar R (2017) Risk factors for coronary artery disease: historical perspectives. Heart Views 18(3):109–114. http://www.heartviews.org/text.asp?2017/18/3/109/217850
Harada M, Van Wagoner DR, Nattel S (2015) Role of inflammation in atrial fibrillation pathophysiology and management. Circ J 79(3):495–502. https://doi.org/10.1253/circj.CJ-15-0138
Hofbauer TM, Mangold A, Scherz T et al (2019) Neutrophil extracellular traps and fibrocytes in ST-segment elevation myocardial infarction. Basic Res Cardiol 114:33. https://doi.org/10.1007/s00395-019-0740-3
Huang LH, Lavine KJ, Randolph GJ (2017) Cardiac lymphatic vessels, transport, and healing of the infarcted heart. JACC Basic Transl Sci 2(4):477–483. https://doi.org/10.1016/j.jacbts.2017.02.005
Hulsmans M, Sam F, Nahrendorf M (2016) Monocyte and macrophage contributions to cardiac remodeling. J Mol Cell Cardiol 93:149–155. https://doi.org/10.1016/j.yjmcc.2015.11.015
Hulsmans M, Clauss S, Xiao L, Aguirre AD, King KR, Hanley A, Hucker WJ et al (2017) Macrophages facilitate electrical conduction in the heart. Cell 169(3):510–522.e20. https://doi.org/10.1016/j.cell.2017.03.050
Hussein AA, Gottdiener JS, Bartz TM, Sotoodehnia N, DeFilippi C, See V, Deo R, Siscovick D, Stein PK, Lloyd-Jones D (2013) Inflammation and sudden cardiac death in a community-based population of older adults: the Cardiovascular Health Study. Heart Rhythm 10(10):1425–1432. https://doi.org/10.1016/j.hrthm.2013.07.004
Imazio M, Brucato A, Maestroni S et al (2011) Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation 123(10):1092–1097. https://doi.org/10.1161/CIRCULATIONAHA.110.986372
Janicki JS, Brower GL, Levick SP (2015) The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling. Methods Mol Biol 1220:121–139. https://doi.org/10.1007/978-1-4939-1568-2_8
Karatolios K, Pankuweit S, Richter A, Ruppert V, Maisch B (2016) Anticardiac antibodies in patients with chronic pericardial effusion. Dis Markers 9262741. https://doi.org/10.1155/2016/9262741
Kaur K, Jalife J (2017) Is TGF-β1 (transforming growth factor-β1) an enabler of Myofibroblast-cardiomyocyte cross talk? Circ Arrhythm Electrophysiol 10(5):e005289. https://doi.org/10.1161/CIRCEP.117.005289
Kouvas N, Kontogiannis C, Georgiopoulos G et al (2018) The complex crosstalk between inflammatory cytokines and ventricular arrhythmias. Cytokine 111:171–177. https://doi.org/10.1016/j.cyto.2018.08.007
Krause PJ, Bockenstedt LK (2013) Cardiology patient pages. Lyme disease and the heart. Circulation 127(7):e451–e454. https://doi.org/10.1161/CIRCULATIONAHA.112.101485
Lavine KJ, Pinto AR, Epelman S et al (2018) The macrophage in cardiac homeostasis and disease: JACC macrophage in CVD series (part 4). J Am Coll Cardiol 72(18):2213–2230. https://doi.org/10.1016/j.jacc.2018.08.2149
Lazzerini PE, Capecchi PL, Laghi-Pasini F (2015) Long QT syndrome: an emerging role for inflammation and immunity. Front Cardiovasc Med 2:26. https://doi.org/10.3389/fcvm.2015.00026
Lazzerini PE, Capecchi PL, Laghi-Pasini F, Boutjdir M (2017) Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias. Nat Rev Cardiol 14(9):521–535. https://doi.org/10.1038/nrcardio.2017.61
Leid J, Carrelha J, Boukarabila H, Epelman S, Jacobsen SE, Lavine KJ (2016) Primitive embryonic macrophages are required for coronary development and maturation. Circ Res 118:1498–1511. https://doi.org/10.1161/CIRCRESAHA.115.308270
Levick SP, Widiapradja A (2018) Mast cells: key contributors to cardiac fibrosis. Int J Mol Sci 19(1):231. https://doi.org/10.3390/ijms19010231
Levick SP, Meléndez GC, Plante E, McLarty JL, Brower GL, Janicki JS (2011) Cardiac mast cells: the centrepiece in adverse myocardial remodelling. Cardiovasc Res 89(1):12–19. https://doi.org/10.1093/cvr/cvq272
Li W, Hsiao HM, Higashikubo R, Saunders BT, Bharat A, Goldstein DR, Krupnick AS, Gelman AE, Lavine KJ, Kreisel D (2016) Heart-resident CCR2+ macrophages promote neutrophil extravasation through TLR9/MyD88/CXCL5 signaling. JCI Insight 1(12):e87315. https://doi.org/10.1172/jci.insight.87315
Linton MRF, Yancey PG, Davies SS, et al (2000) The role of lipids and lipoproteins in atherosclerosis. [Updated 2019 Jan 3]. In: Feingold KR, Anawalt B, Boyce A, et al (eds). Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc. https://www.ncbi.nlm.nih.gov/books/NBK343489/
Liu G, Yan YP, Zheng XX et al (2014) Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of atrial fibrillation. Am J Cardiol 114(10):1523–1529. https://doi.org/10.1016/j.amjcard.2014.08.015
Lubos E, Handy DE, Loscalzo J (2008) Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci 13:5323–5344. https://doi.org/10.2741/3084
Ma Y, Mouton AJ, Lindsey ML (2018) Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Transl Res 191:15–28. https://doi.org/10.1016/j.trsl.2017.10.001
Machado FS, Tanowitz HB, Ribeiro AL (2013) Pathogenesis of chagas cardiomyopathy: role of inflammation and oxidative stress. J Am Heart Assoc 2(5):e000539. https://doi.org/10.1161/JAHA.113.000539
Marchio P, Guerra-Ojeda S, Vila JM, Aldasoro M, Victor VM, Mauricio MD (2019) Targeting early atherosclerosis: a focus on oxidative stress and inflammation. Oxidative Med Cell Longev 2019:8563845. https://doi.org/10.1155/2019/8563845
Martini E, Kunderfranco P, Peano C et al (2019) Single-cell sequencing of mouse heart immune infiltrate in pressure overload-driven heart failure reveals extent of immune activation. Circulation 140(25):2089–2107. https://doi.org/10.1161/CIRCULATIONAHA.119.041694
Mayorga M, Kiedrowski M, Shamhart P, Forudi F, Weber K, Chilian WM, Penn MS, Dong F (2016) Early upregulation of myocardial CXCR4 expression is critical for dimethyloxalylglycine-induced cardiac improvement in acute myocardial infarction. Am J Physiol Heart Circ Physiol 310(1):H20–H28. https://doi.org/10.1152/ajpheart.00449.2015
Mayosi BM, Burgess LJ, Doubell AF (2005) Tuberculous pericarditis. Circulation 112(23):3608–3616. https://doi.org/10.1161/CIRCULATIONAHA.105.543066
Moore KJ, Sheedy FJ, Fisher EA (2013) Macrophages in atherosclerosis: a dynamic balance. Nature reviews. Immunology 13(10):709–721. https://doi.org/10.1038/nri3520
Mora S, Ridker PM (2006) Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)-can C-reactive protein be used to target statin therapy in primary prevention? Am J Cardiol 97(2A):33A–41A. https://doi.org/10.1016/j.amjcard.2005.11.014
Murillo H, Restrepo CS, Marmol-Velez JA, Vargas D, Ocazionez D, Martinez-Jimenez S, Reddick RL, Baxi AJ (2016) Infectious diseases of the heart: pathophysiology. Clin Imaging Overv. https://doi.org/10.1148/rg.2016150225
Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S et al (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41(1):14–20. https://doi.org/10.1016/j.immuni.2014.06.008
Nehring SM, Goyal A, Bansal P, et al (2020) C Reactive Protein (CRP) [Updated 2020 Mar 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441843/
Ngkelo A, Richart A, Kirk JA, Bonnin P, Vilar J, Lemitre M, Marck P et al (2016) Mast cells regulate myofilament calcium sensitization and heart function after myocardial infarction. J Exp Med 213:1353–1374. https://doi.org/10.1084/jem.20160081
Nguyen MT, Fernando S, Schwarz N, Tan JT, Bursill CA, Psaltis PJ (2019) Inflammation as a therapeutic target in atherosclerosis. J Clin Med 8(8):1109. https://doi.org/10.3390/jcm8081109
Papathanasiou S, Rickelt S, Soriano ME et al (2015) Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18. Nat Med 21(9):1076–1084. https://doi.org/10.1038/nm.3925
Pearson TA, Mensah GA, Alexander RW et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499–511. https://doi.org/10.1161/01.cir.0000052939.59093.45
Peet C, Ivetic A, Bromage DI, Shah AM (2020) Cardiac monocytes and macrophages after myocardial infarction. Cardiovasc Res:cvz336. https://doi.org/10.1093/cvr/cvz336
Prabhu SD, Frangogiannis NG (2016) The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res 119:91–112. https://doi.org/10.1161/CIRCRESAHA.116.303577
Puhl SL, Steffens S (2019) Neutrophils in post-myocardial infarction inflammation: damage vs. resolution? Front Cardiovasc Med 6:25. https://doi.org/10.3389/fcvm.2019.00025
Ramasamy V, Mayosi BM, Sturrock ED, Ntsekhe M (2018) Established and novel pathophysiological mechanisms of pericardial injury and constrictive pericarditis. World J Cardiol 10(9):87–96. https://doi.org/10.4330/wjc.v10.i9.87
Ramos GC, van den Berg A, Nunes-Silva V, Weirather, et al. (2017) Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A 114(12):E2420–E2429. https://doi.org/10.1073/pnas.1621047114
Reber LL, Sibilano R, Mukai K, Ga lli SJ. (2015) Potential effector and immunoregulatory functions of mast cells in mucosal immunity. Mucosal Immunol 8(3):444–463. https://doi.org/10.1038/mi.2014.131
Ridker PM, Lüscher TF (2014) Anti-inflammatory therapies for cardiovascular disease. Eur Heart J 35(27):1782–1791. https://doi.org/10.1093/eurheartj/ehu203
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH et al (2017) CANTOS Trial Group, Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med 377:1119–1131. https://doi.org/10.1056/NEJMoa1707914
Ridker PM, MacFadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ (2018) Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet 391:319–328. https://doi.org/10.1016/S0140-6736(17)32814-3
Rubio PEA, Molina RB, Ávila PEA, Mora AG, López CAG (2019) Infective endocarditis: inflammatory response, genetic susceptibility, oxidative stress, and multiple organ failure. Infective endocarditis. Access date: 13.05.2020. https://doi.org/10.5772/intechopen.84908
Rudolph V, Andrié RP, Rudolph TK et al (2010) Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 16(4):470–474. https://doi.org/10.1038/nm.2124
Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P et al (2012) Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 2379(9822):1205–1213. https://doi.org/10.1016/S0140-6736(11)61931-4
Savvatis K, Muller I, Frohlich M, Pappritz K, Zietsch C, Hamdani N et al (2014) Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis. Basic Res Cardiol 109:449. https://doi.org/10.1007/s00395-014-0449-2
Saxena A, Bujak M, Frunza O, Dobaczewski M, Gonzalez-Quesada C, Lu B et al (2014) CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans. Cardiovasc Res 103:217–227. https://doi.org/10.1093/cvr/cvu138
Segers D, Lipton JA, Leenen PJ, Cheng C, Tempel D, Pasterkamp G, Moll FL, de Crom R, Krams R (2011) Atherosclerotic plaque stability is affected by the chemokine CXCL10 in both mice and humans. Int J Inflamm:936109. https://doi.org/10.4061/2011/936109
Shiraishi M, Shintani Y, Shintani Y, Ishida H, Saba R, Yamaguchi A et al (2016) Alternatively activated macrophages determine repair of the infarcted adult murine heart. J Clin Investig 126:2151–2166. https://doi.org/10.1172/JCI85782
Shrivastava AK, Singh HV, Raizada A, Singh SK (2015) C-reactive protein, inflammation and coronary heart disease. Egypt Heart J 67:89–97. https://doi.org/10.1016/j.ehj.2014.11.005
Smorodinova N, Bláha M, Melenovský V et al (2017) Analysis of immune cell populations in atrial myocardium of patients with atrial fibrillation or sinus rhythm. PLoS One 12(2):e0172691. https://doi.org/10.1371/journal.pone.0172691
Sun Z, Zhou D, Xie X et al (2016) Cross-talk between macrophages and atrial myocytes in atrial fibrillation. Basic Res Cardiol 111(6):63. https://doi.org/10.1007/s00395-016-0584-z
Swirski FK, Nahrendorf M (2018) Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat Rev Immunol 18(12):733–744. https://doi.org/10.1038/s41577-018-0065-8
Szentes V, Gazdag M, Szokodi I, Dézsi CA (2018) The role of CXCR3 and associated chemokines in the development of atherosclerosis and during myocardial infarction. Front Immunol 9:1932. https://doi.org/10.3389/fimmu.2018.01932
Tan HY, Wang N, Li S, Hong M, Wang X, Feng Y (2016) The reactive oxygen species in macrophage polarization: reflecting its dual role in progression and treatment of human diseases. Oxidative Med Cell Longev 2016:2795090. https://doi.org/10.1155/2016/2795090
Tsai CT, Wu CK, Lee JK et al (2015) TNF-α down-regulates sarcoplasmic reticulum Ca2+ ATPase expression and leads to left ventricular diastolic dysfunction through binding of NF-κB to promoter response element. Cardiovasc Res 105(3):318–329. https://doi.org/10.1093/cvr/cvv008
Van Linthout S, Tschöpe C (2017) Inflammation - cause or consequence of heart failure or both? Curr Heart Fail Rep 14(4):251–265. https://doi.org/10.1007/s11897-017-0337-9
Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V (2015) Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science 349:316–320. https://doi.org/10.1126/science.aaa8064
Weil BR, Neelamegham S (2019) Selectins and immune cells in acute myocardial infarction and post-infarction ventricular remodeling: pathophysiology and novel treatments. Front Immunol 10:300. https://doi.org/10.3389/fimmu.2019.00300
Widhe M, Jarefors S, Ekerfelt C et al (2004) Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J Infect Dis 189(10):1881–1891. https://doi.org/10.1086/382893
Yang KC, Kyle JW, Makielski JC, Dudley SC Jr (2015) Mechanisms of sudden cardiac death: oxidants and metabolism. Circ Res 116(12):1937–1955. https://doi.org/10.1161/CIRCRESAHA.116.304691
You L, Wang P, Lv J, Cianflone K, Wang D, Zhao C (2010) The role of high-sensitivity C-reactive protein, interleukin-6 and cystatin C in ischemic stroke complicating atrial fibrillation. J Huazhong Univ Sci Technolog Med Sci 30(5):648–651. https://doi.org/10.1007/s11596-010-0558-6
Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, Blumenthal RS, Budoff MJ (2013) High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol 62(5):397–408. https://doi.org/10.1016/j.jacc.2013.05.016
Zhang Q, Deng Y, Lai W, Guan X, Sun X, Han Q, Wang F et al (2016) Maternal inflammation activated ROS-p38 MAPK predisposes offspring to heart damages caused by isoproterenol via augmenting ROS generation. Sci Rep 6:30146. https://doi.org/10.1038/srep30146
Zhang HF, Wang YL, Tan YZ, Wang HJ, Tao P, Zhou P (2019) Enhancement of cardiac lymphangiogenesis by transplantation of CD34+VEGFR-3+ endothelial progenitor cells and sustained release of VEGF-C. Basic Res Cardiol 114(6):43. https://doi.org/10.1007/s00395-019-0752-z
Acknowledgements
Figures were created with BioRender. This work was supported by the Scientific and Technological Research Council of Turkey (TUBITAK) under Grant No: 218S841.
Conflict of Interest
None.
Ethical Approval
The authors declare that this article does not contain any studies with human participants or animals.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Koc, A., Cagavi, E. (2020). Cardiac Immunology: A New Era for Immune Cells in the Heart. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 11. Advances in Experimental Medicine and Biology(), vol 1312. Springer, Cham. https://doi.org/10.1007/5584_2020_576
Download citation
DOI: https://doi.org/10.1007/5584_2020_576
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71924-1
Online ISBN: 978-3-030-71925-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)